|
GXYLT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04410000001387E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.830500E-04 |
| Normal-vs-Stage2 |
4.950400E-02 |
| Normal-vs-Stage3 |
4.792900E-04 |
| Normal-vs-Stage4 |
1.188210E-01 |
| Stage1-vs-Stage2 |
9.472600E-01 |
| Stage1-vs-Stage3 |
1.795560E-02 |
| Stage1-vs-Stage4 |
3.512600E-01 |
| Stage2-vs-Stage3 |
1.170370E-01 |
| Stage2-vs-Stage4 |
4.703600E-01 |
| Stage3-vs-Stage4 |
6.437000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89903999999741E-05 |
| Normal-vs-AfricanAmerican |
1.098300E-03 |
| Normal-vs-Asian |
3.743800E-01 |
| Caucasian-vs-AfricanAmerican |
5.634800E-01 |
| Caucasian-vs-Asian |
7.263800E-01 |
| AfricanAmerican-vs-Asian |
6.236000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.48309999999674E-05 |
| Normal-vs-Female |
2.49139999999315E-05 |
| Male-vs-Female |
9.784200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.441500E-02 |
| Normal-vs-Extreme_Weight |
8.179600E-03 |
| Normal-vs-Obese |
2.12299999999832E-05 |
| Normal-vs-Extreme_Obese |
3.081800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.309400E-01 |
| Normal_Weight-vs-Obese |
1.598790E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.264200E-01 |
| Extreme_Weight-vs-Obese |
2.693800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.469000E-01 |
| Obese-vs-Extreme_Obese |
5.714400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.069700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.94559999997257E-06 |
| Normal-vs-Age(61-80Yrs) |
9.188100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.222800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.640200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.281350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.310200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.389600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.269000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.788400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.436030E-03 |
| Normal-VS-Type2 PRCC |
1.198170E-03 |
| Normal-VS-KIRP CIMP |
1.161800E-02 |
| Normal-VS-Unclassified PRCC |
5.55059999999274E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.042000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.218800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.040490E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.284100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.036400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.594200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.054460E-02 |
| Normal-vs-N1 |
6.835400E-04 |
| Normal-vs-N2 |
3.386200E-01 |
| N0-vs-N1 |
2.371700E-02 |
| N0-vs-N2 |
4.770000E-01 |
| N1-vs-N2 |
7.504000E-01 |
|
|
